![]() |
同义名 : | - |
CAS号 : | 1308631-40-4 | |
货号 : | A1210845 | |
分子式 : | C13H9ClFNO2 | |
纯度 : | 99%+ | |
分子量 : | 265.67 | |
MDL号 : | MFCD13200880 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | NDMC101 effectively suppresses osteoclastogenesis by reducing osteoclast differentiation through the downregulation of NFATc1-mediated gene expression. It mimics the DPP4 substrate, significantly hindering early T-cell activation by inhibiting DPP4. NDMC101 is suitable for researching bone conditions, including rheumatoid arthritis and synovial inflammation, among others[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.76mL 0.75mL 0.38mL |
18.82mL 3.76mL 1.88mL |
37.64mL 7.53mL 3.76mL |
参考文献 |
---|